![Valerie Start](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Valerie Start
Directeur/Membre du Conseil chez ERASCA, INC.
Fortune : 51 920 $ au 30/06/2024
Profil
Valerie Denise Harding Start is currently an Independent Director at Erasca, Inc., a Member & Partner at Smallify LLC, and the Principal of Start Pharma Consulting LLC.
She previously worked as the Vice President-Product Differentiation at Pfizer Inc. from 2009 to 2012 and as the Senior VP-Chemistry, Manufacturing & Controls at Ignyta, Inc. from 2015 to 2019.
Dr. Start has an undergraduate degree from the University of London and a doctorate degree from The University of Nottingham.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ERASCA, INC.
0,01% | 20/06/2024 | 22 000 ( 0,01% ) | 51 920 $ | 30/06/2024 |
Postes actifs de Valerie Start
Sociétés | Poste | Début |
---|---|---|
ERASCA, INC. | Directeur/Membre du Conseil | 01/06/2019 |
Start Pharma Consulting LLC | Corporate Officer/Principal | 01/02/2019 |
Smallify LLC
![]() Smallify LLC Miscellaneous Commercial ServicesCommercial Services Smallify LLC provides consulting, training, certification, and tools to help organizations implement rapid innovation practices. | Corporate Officer/Principal | - |
Anciens postes connus de Valerie Start
Sociétés | Poste | Fin |
---|---|---|
IGNYTA INC | Corporate Officer/Principal | 01/01/2019 |
PFIZER, INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Valerie Start
University of London | Undergraduate Degree |
The University of Nottingham | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
PFIZER, INC. | Health Technology |
ERASCA, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Ignyta, Inc.
![]() Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Smallify LLC
![]() Smallify LLC Miscellaneous Commercial ServicesCommercial Services Smallify LLC provides consulting, training, certification, and tools to help organizations implement rapid innovation practices. | Commercial Services |
Start Pharma Consulting LLC |